Perimenopause Supplements: What the Evidence Actually Shows

Walk into a food co-op in Portland or a pharmacy in Portsmouth and perimenopause supplements have their own shelf, with labels promising balance and support. Most of what sits there has not been shown to relieve hot flashes or night sweats. In its 2023 nonhormone therapy position statement, The Menopause Society reviewed the evidence and did not recommend supplements or herbal remedies for those symptoms, and it named soy foods, soy extracts and the soy metabolite equol as not recommended. Vitamin D and calcium are a different case: they matter during perimenopause for bone rather than for symptom relief, because bone loss speeds up about a year before the final menstrual period. Even there the ground is soft. The US Preventive Services Task Force found no net benefit from lower dose vitamin D plus calcium supplements for preventing fractures in postmenopausal women.

That is not a small market being brushed aside. A 2016 JAMA review noted that 40% to 50% of women in Western countries use complementary therapies for menopausal symptoms. The question is what got measured.

What happened when perimenopause supplements were tested

The clearest test is old and well built. The HALT trial randomized 351 women aged 45 to 55 having at least two vasomotor symptoms a day, about half still in the menopausal transition. Arms included black cohosh, two multibotanical regimens, hormone therapy, and placebo. The gap between placebo and any herbal arm never reached a full symptom a day, and averaged under 0.55 across follow-up. Hormone therapy separated from placebo by about four. Black cohosh, the authors wrote, “shows little potential as an important therapy for relief of vasomotor symptoms.”

The largest look at plant based options pooled 62 randomized trials covering 6,653 women for JAMA in 2016. Phytoestrogens were associated with about 1.31 fewer hot flashes a day, soy isoflavones with 0.79. Night sweats did not improve significantly. Then read the quality column: 46 of those 62 trials, 74%, carried a high risk of bias in three or more areas. A modest average drawn from mostly weak trials is a modest signal.

Omega-3s got a cleaner answer. Pooling three MsFLASH trials, 899 perimenopausal and postmenopausal women with at least 14 bothersome symptoms a week, researchers found omega-3 supplementation had no effect on symptom frequency or bother. Nonaerobic yoga and aerobic exercise showed nothing either. Magnesium sits on nearly every one of these shelves and has a literature of its own, which we went through in our magnesium comparison. The federal menopause overview does not evaluate it at all.

Black cohosh is where the honest answer gets complicated

Anyone who says black cohosh plainly works, or plainly does not, is stepping over a real disagreement. The Menopause Society does not recommend it, and HALT found it no better than placebo. But the National Center for Complementary and Integrative Health reports on its black cohosh page that a 2023 review of 22 studies of products containing black cohosh extracts found them potentially beneficial for overall menopause symptoms, with improvement in hot flashes but not in anxiety or depressive symptoms. NCCIH’s own menopause overview is cooler: “not enough evidence to support its use for menopause symptoms.” Two pages, one federal agency, two readings.

What the label does not tell you

The FDA says it “does not have the authority to approve dietary supplements before they are marketed,” and that manufacturers and distributors “are responsible for evaluating the safety and labeling of their products before marketing.” Oversight arrives after a product reaches the shelf, which is not the same as the popular shorthand that supplements are unregulated.

Product identity is where that bites. NCCIH notes that some commercial black cohosh products “have been found to contain the wrong herb or to contain mixtures of black cohosh and other herbs that are not listed on the label.” The NIDDK LiverTox database records more than fifty instances of clinically apparent liver injury linked to products labeled as black cohosh, some requiring a transplant or ending in death. The same entry notes that prospective trials in more than 1,200 patients found no such injury, that the responsible ingredient is unknown, and that some retrieved products contained Chinese Actaea species. The risk attaches to products sold as black cohosh. NCCIH also says St. John’s wort, promoted for menopause symptoms, “can interact in dangerous, sometimes life-threatening ways with a variety of medicines,” including birth control pills and warfarin, and that kava supplements “have been linked to a risk of severe liver disease.” A pharmacist can check a bottle against your prescriptions in a minute.

The one bottle with a northern New England rationale

Vitamin D is the exception up here, and not for the reason the label suggests. In 1988, Webb, Kline and Holick exposed human skin to cloudless winter sunlight in Boston, at 42.2 degrees north, and measured no previtamin D3 production at all from November through February. Farther north, in Edmonton at 52 degrees, it ran October through March. Every town in Maine and New Hampshire sits north of Boston’s latitude. The authors called it a vitamin D winter and wrote that dietary supplementation during it may be advisable. That is a nutrient question, not a hot flash question.

What it connects to is bone, and the timing is precise. In the Study of Women’s Health Across the Nation, density loss began a year before the final menstrual period and slowed two years after it. Across ten years, lumbar spine density fell 10.6%, and 7.38 of those points went inside that window. The USPSTF recommendation against lower dose vitamin D with calcium is a Grade D scoped to community dwelling postmenopausal women, at or below 400 IU with 1,000 mg or less of calcium. Above those amounts, and for premenopausal women, it calls the evidence insufficient, on a page marked as an update in progress. A 46 year old who still gets periods sits outside it entirely. The NIH Office of Dietary Supplements is careful in the same way, saying it “is not clear whether calcium supplements help prevent fractures.”

Why anyone can point at that shelf

There is a legal reason a co-op clerk and a licensed clinician can both recommend the same bottle. Maine regulates naturopathic medicine through a dedicated state board (32 MRSA 12502), and 32 MRSA 12522(1) places “food, food extracts, vitamins, minerals … plant substances, all homeopathic preparations” inside that licensed scope. Then the same subsection says it “may not be construed to prevent an individual other than a naturopathic doctor from using, ordering or recommending any of the above listed items.” The shelf is legal, and legal describes who may sell and suggest. It says nothing about whether the contents work.

What the same guideline does recommend

The 2023 statement that declines to recommend supplements is not empty-handed. At its strongest level of evidence it recommends cognitive behavioral therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin and fezolinetant. It also states that hormone therapy “remains the most effective treatment for vasomotor symptoms.” Whether any of it fits you is a clinician’s conversation. The HHS Office on Women’s Health says hormone blood testing is not usually recommended to identify perimenopause, because “hormone levels go up and down in an unpredictable way during the transition to menopause.” And ACOG notes that bleeding may become heavier or lighter during the transition. Heavier bleeding is a reason to be seen. For the wider map, we walked through what changes and when.

None of this makes the shelf a fraud. It makes it a shelf. The strongest evidence in perimenopause sits with things nobody sells in a bottle.

Sources

• The North American Menopause Society. “The 2023 nonhormone therapy position statement of The North American Menopause Society,” Menopause 2023;30(6):573-590. https://pubmed.ncbi.nlm.nih.gov/37252752/
• Newton, K.M., et al. “Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial,” Annals of Internal Medicine 2006;145(12):869-79. https://pubmed.ncbi.nlm.nih.gov/17179056/
• Franco, O.H., et al. “Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis,” JAMA 2016;315(23):2554-63. https://pubmed.ncbi.nlm.nih.gov/27327802/
• Guthrie, K.A., et al. “Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms,” Obstetrics and Gynecology 2015;126(2):413-422. https://pubmed.ncbi.nlm.nih.gov/26241433/
• National Center for Complementary and Integrative Health. “Menopausal Symptoms: In Depth.” https://www.nccih.nih.gov/health/menopausal-symptoms-in-depth
• National Center for Complementary and Integrative Health. “Black Cohosh: Usefulness and Safety.” https://www.nccih.nih.gov/health/black-cohosh
• National Center for Complementary and Integrative Health. “St. John’s Wort.” https://www.nccih.nih.gov/health/st-johns-wort
• National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Black Cohosh. https://www.ncbi.nlm.nih.gov/books/NBK547990/
• US Food and Drug Administration. “Questions and Answers on Dietary Supplements.” https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
• US Preventive Services Task Force. “Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication.” https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
• Greendale, G.A., et al. “Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women’s Health Across the Nation (SWAN),” Journal of Bone and Mineral Research 2012;27(1):111-8. https://pubmed.ncbi.nlm.nih.gov/21976317/
• NIH Office of Dietary Supplements. “Calcium: Fact Sheet for Consumers.” https://ods.od.nih.gov/factsheets/Calcium-Consumer/
• Webb, A.R., Kline, L., Holick, M.F. “Influence of season and latitude on the cutaneous synthesis of vitamin D3,” Journal of Clinical Endocrinology and Metabolism 1988;67(2):373-8. https://pubmed.ncbi.nlm.nih.gov/2839537/
• Maine Revised Statutes, Title 32, Section 12502, Board of Complementary Health Care Providers established. Office of the Revisor of Statutes. https://legislature.maine.gov/statutes/32/title32sec12502.html
• Maine Revised Statutes, Title 32, Section 12522, Scope of practice. Office of the Revisor of Statutes. https://legislature.maine.gov/statutes/32/title32sec12522.html
• American College of Obstetricians and Gynecologists. “Perimenopausal Bleeding and Bleeding After Menopause” (FAQ). https://www.acog.org/womens-health/faqs/perimenopausal-bleeding-and-bleeding-after-menopause
• US Department of Health and Human Services, Office on Women’s Health. “Menopause basics.” https://www.womenshealth.gov/menopause/menopause-basics

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any health decisions.